| A Clinical Study to Investigate the Safety and Immunogenicity in Relation to Product Attributes of mRNA-1083 (Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2] and Influenza Vaccine) (NCT06508320) | ModernaTX, Inc. | 2024-07-15 |
| Adebrelimab in Combination With Apatinib and Chemotherapy/Chemoradiotherapy in Immuno-experienced Second-line ESCC. (NCT06464614) | The First Affiliated Hospital of Henan University of Science and Technology | 2024-07-15 |
| Comparison of Post-Inflammatory Pigment Alteration After Psoriasis Treatment (PIPA - Dermavant) (NCT05981118) | Wake Forest University Health Sciences | 2024-07-15 |
| Lerapolturev (PVSRIPO) in GBM (NCT06177964) | Darell Bigner | 2024-07-15 |
| Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation (NCT06440850) | City of Hope Medical Center | 2024-07-15 |
| RIC With Thiotepa Combined With Bu/Flu/Ara-C in Allo-HSCT for Relapsed or Refractory PTCL. (NCT06468267) | Xianmin Song, MD | 2024-07-15 |
| A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Participants With Unresectable Hepatocellular Carcinoma and Child-pugh B7 and B8 Cirrhosis (NCT06096779) | Genentech, Inc. | 2024-07-15 |
| Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study (NCT06534762) | Zhejiang Provincial People's Hospital | 2024-07-15 |
| Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer (NCT06029270) | National Cancer Institute (NCI) | 2024-07-15 |
| SBRT and LDRT Combined With PD-1 Antibody and Chemotherapy in r/m Nasopharyngeal Carcinoma (NCT06323239) | Sun Yat-sen University | 2024-07-15 |
| Evaluate the Safety and Efficacy of HDM1002 Tablets in Overweight and Obese Adults (NCT06500299) | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 2024-07-15 |
| PD-L1 Inhibitor Combined With Apatinib as First-line Maintenance Treatment for Extensive-stage Small Cell Lung Cancer (NCT06429696) | Nanfang Hospital, Southern Medical University | 2024-07-14 |
| Early Interferon-beta Treatment for West-Nile Virus Infection (NCT06510426) | Tel-Aviv Sourasky Medical Center | 2024-07-14 |
| A Study of Adebrelimab Combined With Chemoradiotherapy in the Treatment of Esophageal Small Cell Carcinoma (NCT06478264) | Zhangzhou Municipal Hospital | 2024-07-13 |
| Study on Optimization and Evaluation of Integrated Chinese and Western Medicine for pSS Glandular Damage (NCT06519617) | Qingwen Tao | 2024-07-13 |
| A Study of Atlacabtagene Autoleucel CAR T-cells for Adults With Relapsed Large B-cell Lymphoma (NCT06486051) | Malaghan Institute of Medical Research | 2024-07-12 |
| A Clinical Study of B007 in the Treatment of Pemphigus. (NCT06454357) | Shanghai Jiaolian Drug Research and Development Co., Ltd | 2024-07-12 |
| Efficacy and Safety of Silfamin for Common Cold (NCT06497439) | Dexa Medica Group | 2024-07-12 |
| Safety, Pharmacokinetics, and Plasmodium Falciparum Transmission-reducing Activity of Monoclonal Antibody TB31F in Mali (NCT06413108) | Radboud University Medical Center | 2024-07-12 |
| Modified SCRT Followed by Tislelizumab Plus CAPOX for Locally Advanced Rectal Cancer (NCT06333769) | Fujian Cancer Hospital | 2024-07-12 |
| CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant (NCT06059391) | City of Hope Medical Center | 2024-07-12 |
| Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination with Pembrolizumab, in Unresectable Melanoma Patients (NCT06284590) | Philogen S.p.A. | 2024-07-12 |
| A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017) (NCT06465186) | Merck Sharp & Dohme LLC | 2024-07-12 |
| Adding Dexmedetomidine to Mannitol to Attenuate the Increase of Intracranial Pressure (NCT07064720) | Cairo University | 2024-07-12 |
| DapagliFLOzin in Renal AL Amyloidosis (FLORAL) (NCT06420167) | Barbara Ann Karmanos Cancer Institute | 2024-07-11 |
| A Study of B013 in Combination With Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer. (NCT06434610) | Shanghai Jiaolian Drug Research and Development Co., Ltd | 2024-07-11 |
| Phase Ib/II Study Assessing the Clinical Activity and Safety of Brexucabtagene Autoleucel as a Consolidation in Patients With Relapsed/Refractory (R/R) and Newly Diagnosed B-cell Acute Lymphocytic Leukemia (ALL) Post Cytoreduction With Mini-HCVD-inotuzumab-blinatumomab/HCVAD-inotuzumab-blinatumomab (NCT06287229) | M.D. Anderson Cancer Center | 2024-07-11 |
| Biomarker Based Neoadjuvant Strategies for Locally Advanced Resectable ESCC (NCT06601309) | Fujian Medical University Union Hospital | 2024-07-11 |
| A Study to Learn About the Study Medicine PF-07220060 Together With Letrozole Compared to Letrozole Alone in Women Post Menopause (NCT06465368) | Pfizer | 2024-07-11 |
| Phase I/II Study of IPG1094 in Advanced Solid Tumors Patients (NCT06212076) | Nanjing Immunophage Biotech Co., Ltd | 2024-07-11 |
| A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity (NCT06046443) | Rhythm Pharmaceuticals, Inc. | 2024-07-11 |
| Combination of Orelabrutinib and Obinutuzumab in Untreated Marginal Zone Lymphomas (NCT06513234) | Institute of Hematology & Blood Diseases Hospital, China | 2024-07-11 |
| Cadonilimab Combined With Regorafenib as A Third-line Treatment in Patients With MSS CRLM (NCT06455254) | Jin-hong Chen | 2024-07-11 |
| Dupilumab in the Treatment of Pediatric Alopecia Areata (NCT05866562) | Icahn School of Medicine at Mount Sinai | 2024-07-11 |
| Efficacy and Safety of T-DXd in HER2-mutant Advanced Lung Cancer Patients With Asymptomatic Brain Metastases (NCT06250777) | Yonsei University | 2024-07-11 |
| Lymphocyte Support to SBRT in Patients With Oligo-metastatic Solid Cancer (NCT06439888) | Gustave Roussy, Cancer Campus, Grand Paris | 2024-07-11 |
| A Dose Finding Study to Assess Efficacy and Safety of IBI128 in Chinese Gout Subjects (NCT06501534) | Innovent Biologics (Suzhou) Co. Ltd. | 2024-07-10 |
| Comparison of EOSP Between Usg Guided S-FICB vs USG Guided PENG Block in Pts Undergoing Femur Fracture Surgery (NCT06568770) | Sahiwal medical college sahiwal | 2024-07-10 |
| Testing the Combination of the Anticancer Drug Durvalumab With Chemotherapy (Gemcitabine and Cisplatin) at Improving Outcomes for High-Risk Resectable Liver Cancer Before Surgery (NCT06050252) | National Cancer Institute (NCI) | 2024-07-10 |
| Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease (NCT05907759) | National Cancer Institute (NCI) | 2024-07-10 |
| Study of Complication Rates in Cataract Surgery Patients Treated With Combined Pre-operative NSAID, OMIDRIA, and Subconjunctival Triamcinolone Acetonide Compared With Peri-operative SOC (NCT06681688) | Inder Paul Singh, M.D. | 2024-07-10 |
| Cadonilimab Combination Regimen as First-line Treatment for HER2-expressing GC/GEJ Patients (NCT06650332) | Zhejiang Cancer Hospital | 2024-07-10 |
| Mechanisms of Semaglutide Therapy in Heart Failure Patients (NCT06541509) | University Medical Centre Ljubljana | 2024-07-10 |
| Dose Finding, Efficacy and Immunological Response of IP-001 Following MWA or IRE for CRLM (NCT06630624) | M.R. Meijerink | 2024-07-10 |
| Sequential CAR-T Cells Therapy for CD5/CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD5/CD7-Specific CAR-T Cells (NCT06420076) | Essen Biotech | 2024-07-10 |
| Low-dose Radiotherapy Combined With Chemotherapy and AK112 as Second-line Treatment in Patients With Advanced G/GEJ Cancer (NCT06791148) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2024-07-10 |
| Combination of Zanubrutinib, Rituximab and Venetoclax in Patients With Previously Untreated Follicular Lymphoma (NCT06471738) | Chinese PLA General Hospital | 2024-07-10 |
| Sequential CAR-T Cells Targeting CD33/CD123 in Patients With Acute Myelocytic Leukemia AML (NCT06420063) | Essen Biotech | 2024-07-10 |
| Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer (NCT04915183) | National Institute on Deafness and Other Communication Disorders (NIDCD) | 2024-07-10 |
| Fourth-gen CAR T Cells Targeting CD19/CD22 for Highly Resistant B-cell Lymphoma/Leukemia (PMBCL/CNS-BCL). (NCT06213636) | Essen Biotech | 2024-07-10 |
| Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB). (NCT06550128) | Ausper Biopharma Co., Ltd. | 2024-07-10 |
| Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer (NCT06208657) | Australian & New Zealand Children's Haematology/Oncology Group | 2024-07-10 |
| Evaluation of 611 in Chinese Children and Adolescents With Moderate to Severe Atopic Dermatitis (NCT06324812) | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 2024-07-10 |
| CMOP±R in the Treatment of Untreated Non-Hodgkin's Lymphoma (NCT06486337) | The First Affiliated Hospital of Soochow University | 2024-07-10 |
| Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE) (NCT06350110) | Essen Biotech | 2024-07-10 |
| LM-108 in Combination With PD-1 Based Treatment for Patients With Recurrent or Metastatic Triple - Negative Breast Cancer (NCT06387628) | Fudan University | 2024-07-10 |
| Trial Utilizing Metronidazole to Optimize the Microbiome of Rectal Adenocarcinoma Undergoing Neoadjuvant Therapy (NCT06569368) | M.D. Anderson Cancer Center | 2024-07-10 |
| Preventing of GVHD with Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Ruxolitinib At Children and Young Adults with Hemoblastosis (NCT06756152) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2024-07-10 |
| Astroscape: A Study of Radiprodil on Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavioral Symptoms in Patients With TSC or FCD Type II (NCT06392009) | GRIN Therapeutics, Inc. | 2024-07-10 |
| A Phase lb/lI Clinical Study in Advanced or Metastatic Esophageal Squamous Cell Carcinoma (NCT06487702) | Rui-hua Xu, MD, PhD | 2024-07-10 |
| Lenvatinib Treatment in Waiting List of Liver Transplantation After TACE Failure in Patients With Hepatocellular Carcinoma (NCT05901194) | Assistance Publique - Hôpitaux de Paris | 2024-07-10 |
| Clinical Outcome of Vinpocetine in Diabetic Nephropathy (NCT06441591) | Ain Shams University | 2024-07-10 |
| A Study of GFH375 in Patients With Advanced Solid Tumors With KRAS G12D Mutations (NCT06500676) | Genfleet Therapeutics (Shanghai) Inc. | 2024-07-09 |
| A Study to Assess the Effects of Dexpramipexole in Participants With Eosinophilic COPD (NCT06533553) | Areteia Therapeutics | 2024-07-09 |
| Bright White Light Therapy in Reducing Cancer-Related Fatigue and Depression in Advanced Prostate Cancer Patients Undergoing Treatment With ADT Combination Therapy (NCT05869682) | City of Hope Medical Center | 2024-07-09 |
| SalT Supplementation in Older Adults With Orthostatic Intolerance Disorders (NCT06188663) | University of Galway | 2024-07-09 |
| Polyspecific Antibodies in Lymphoproliferative T-cell Disorders (NCT06495723) | Xenothera SAS | 2024-07-09 |
| Siltuximab for the Prevention of Severe Immune-Related Adverse Events During Immune Checkpoint Inhibitor Rechallenge in Patients With Advanced Cancer, CIRES Trial (NCT06470971) | Yuanquan Yang | 2024-07-09 |
| Dapansutrile in Diabetes and Diabetes-Related Complications - Dapan-Dia (NCT06047262) | Marc Donath | 2024-07-09 |
| Safety and Efficacy of Tocilizumab in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (NCT06452537) | Tianjin Medical University General Hospital | 2024-07-09 |
| Trilaciclib Combined With Concurrent Chemoradiotherapy and Immunotherapy in the Treatment of Esophageal Cancer (NCT06569459) | The First Affiliated Hospital with Nanjing Medical University | 2024-07-09 |
| A Study to Investigate the Safety and Tolerability of TE-8105 in Overweight/Obese Participants Without Diabetes (NCT06471530) | Immunwork, Inc. | 2024-07-09 |
| A Study of AMDX-2011P in Participants With CAA (NCT05709314) | Amydis Inc. | 2024-07-09 |
| Telacebec (T) Treatment in Adults With Buruli Ulcer (BU). (TREAT BU) (NCT06481163) | Barwon Health | 2024-07-09 |
| Comparative Efficacy Of Intraductal Antibiotic During ERCP In Acute Cholangitis (NCT07407491) | National University of Malaysia | 2024-07-09 |
| Study of IPMN Progression Prevention With Tocotrienol (SIPP-T3) (NCT06519097) | H. Lee Moffitt Cancer Center and Research Institute | 2024-07-09 |
| A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer (NCT06380816) | Cancer Research UK | 2024-07-09 |
| Study to Evaluate the Safety and Feasibility of Diamyd® in Individuals at Risk for Type 1 Diabetes (NCT05683990) | Diamyd Medical AB | 2024-07-09 |
| Tolerability and Immunogenicity of a Single 40-ug Dose of rBV A/B for the Production of BabyBIG® (NCT06112834) | California Department of Public Health | 2024-07-09 |
| Safety and Efficacy of VDPHL01 in Males and Females With AGA (NCT06527365) | Veradermics, Inc. | 2024-07-08 |
| Perioperative Gemcitabine, Cisplatin, and Pembrolizumab in Potentially Resectable Biliary Tract Cancers (NCT06001658) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2024-07-08 |
| CBT-I in Primary Brain Tumor Patients: Phase IIc Randomized Feasibility Pilot Trial (NCT06439420) | Virginia Commonwealth University | 2024-07-08 |
| Mitoxantrone Hydrochloride Liposome in Combination With Cytarabine and Venetoclax Regimen in Newly Diagnosed Elderly AML (NCT06621199) | First Affiliated Hospital of Zhejiang University | 2024-07-08 |
| Psilocybin for Treatment-Resistant Depression (NCT06230757) | University of Colorado, Denver | 2024-07-08 |
| Efficacy, Safety, and Dose-response of a Live Biotherapeutic Product in Women With Acute Vaginal Infection (NCT06450990) | NEXBIOME THERAPEUTICS | 2024-07-08 |
| A Study to Evaluate the Efficacy and Safety of AK120 in Subjects With Moderate to Severe Atopic Dermatitis (NCT06700499) | Akeso | 2024-07-08 |
| A Study of Etoposide-carboplatin in Combination With Pembrolizumab and Lenvatinib Maintenance in HG-NETs (NCT06232564) | Imperial College London | 2024-07-08 |
| Effectiveness of Riboflavin-Moxifloxacin Amniotic Membrane as an Adjuvant for PACK-CXL in Moderate to Severe Infectious Keratitis (NCT07559149) | Gadjah Mada University | 2024-07-07 |
| RC48 Plus AK104 as First-line Treatment for HER2-overexpressing Advanced Gastric Cancer (NCT06492317) | The First Affiliated Hospital of Zhengzhou University | 2024-07-06 |
| A Clinical Study Evaluating LY-M001 Injection in the Treatment of Adult Patients With Type I Gaucher Disease (NCT06818838) | Lingyi Biotech Co., Ltd. | 2024-07-05 |
| A Clinical Study on the Efficacy and Safety of Fasudil Hydrochloride Combined With Immunotherapy in the Treatment of Metastatic Castration-resistant Prostate Cancer (NCT07250542) | baotai Liang | 2024-07-05 |
| A Pilot Study of Emapalumab for the Treatment of CAR T-Cell Therapy-Associated Prolonged Cytopenia (NCT06285825) | M.D. Anderson Cancer Center | 2024-07-05 |
| Mitoxantrone Hydrochloride Liposome, Standard-dose of Cytarabine and Venetoclax in the Treatment of R/R AML (NCT06621212) | First Affiliated Hospital of Zhejiang University | 2024-07-05 |
| Study of SPG601 in Adult Men With Fragile X Syndrome (NCT06413537) | Spinogenix | 2024-07-05 |
| A Study of HRS-4642 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation (NCT06385678) | Jiangsu HengRui Medicine Co., Ltd. | 2024-07-05 |
| FcRn Antagonists (Efgartigimod) for Acute NMOSD Attack (NCT06497374) | Tianjin Medical University General Hospital | 2024-07-05 |
| A Study to Explore Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of Novel Therapeutics in Patients With Early Relapsed Metastatic Triple-negative Breast Cancer (NCT06508216) | Gustave Roussy, Cancer Campus, Grand Paris | 2024-07-05 |
| Talazoparib Plus Enzalutamide After Progression to Abiraterone in Metastatic Prostate Cancer: (TEAM PC) (NCT06582628) | Fundacion Oncosur | 2024-07-05 |
| To Explore the Efficacy of Sintilimab Combined With Bevacizumab in Rectal Cancer (NCT06808412) | xiaohua li | 2024-07-05 |
| A Extension Clinical Study of TQC2731 Injection in the Treatment of Chronic Sinusitis With Nasal Polyps (NCT06451640) | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 2024-07-04 |